Skip to main content
SpringerLink
Log in

Gastric Cytoprotection

What Does It Really Mean for the Prescriber?

  • Leading Article
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Aadland E, Fausa O, Vatn M, Cohen H, Quinlan D. Protection by misoprostol against naproxen-induced gastric mucosal damage. American Journal of Medicine 83 (Suppl. 1A): 37–40, 1987

    Article  PubMed  CAS  Google Scholar 

  • Barrier CH, Hirschowitz BI. Controversies in the detection and management of nonsteroidal antiinflammatory drug-induced side effects of the upper gastrointestinal tract. Arthritis and Rheumatism 32: 926–932, 1989

    PubMed  CAS  Google Scholar 

  • Bianchi Porro G, Pace F, Caruso I. Why are non-steroidal anti-inflammatory drugs important in peptic ulceration? Alimentary Pharmacology and Therapeutics 1 (Suppl. 1): 540S–547S, 1987a

    PubMed  CAS  Google Scholar 

  • Bianchi Porro G, Parente F. Side effects of anti-ulcer prostaglandins: an overview of the worldwide clinical experience. Scandinavian Journal of Gastroenterology 24 (Suppl. 164): 224–231, 1989

    Article  Google Scholar 

  • Bianchi Porro G, Parente F, Lazzaroni M. Tripotassium dicitrato bismuthate (TDB) versus two different dosages of cimetidine in the treatment of resistant duodenal ulcers. Gut 28: 907–911, 1987b

    Article  PubMed  CAS  Google Scholar 

  • Bianchi Porro G, Lazzaroni M, Barbara L, Corinaldesi R, Dal Monte PR, et al. Tripotassium dicitrato bismuthate and ranitidine in duodenal ulcer: healing and influence on recurrence. Scandinavian Journal of Gastroenterology 23: 1232–1236, 1988

    Article  PubMed  CAS  Google Scholar 

  • Bolin TD. Sucralfate maintenance therapy in duodenal ulcer disease: a review. American Journal of Medicine 86 (Suppl. 6A): 148–151, 1989

    Article  PubMed  CAS  Google Scholar 

  • Brogden RN, Heel RC, Speight TM, Avery GS. Sucralfate: a review of its pharmacodynamic properties and therapeutic use in peptic ulcer disease. Drugs 27: 194–209, 1984

    Article  PubMed  CAS  Google Scholar 

  • Cipollini F, Altilia F. Comparison of tripotassium di-citrato bismuthate (TDB) with ranitidine in healing and relapse of gastric ulcer. British Journal of Clinical Practice 41: 707–709, 1987

    PubMed  CAS  Google Scholar 

  • Clay GA. Spontaneous relapse rates of healed duodenal ulcers: a comparative assessment of therapeutic agents. Acta Therapeutica 14: 309–319, 1988

    Google Scholar 

  • Cohen MM, Clark L, Armstrong L, D’Souza J. Reduction of aspirin-induced fecal blood loss with low-dose misoprostol tablets in man. Digestive Diseases and Sciences 30: 605–611, 1985a

    Article  PubMed  CAS  Google Scholar 

  • Cohen MM, McCready D, Clark L, Sevelius H. Protection against aspirin-induced antral and duodenal damage with enprostil: a double-blind endoscopic study. Gastroenterology 88: 382–386, 1985b

    PubMed  CAS  Google Scholar 

  • Dobrilla G, Vallaperta P, Amplatz S. Influence of ulcer healing agents on ulcer relapse after discontinuation of acute treatment: a pooled estimate of controlled clinical trials. Gut 29: 181–187, 1988

    Article  PubMed  CAS  Google Scholar 

  • Fedeli G, Anti M, Rapaccini GL, De Vitis I, Brighi S, et al. Pirenzepine versus cimetidine in non ulcer-associated gastritis and duodenitis. Clinical Trials Journal 20: 101–111, 1983

    Google Scholar 

  • George LL, Borody TJ, Andrews P, Devine M, Moore-Jones D, et al. Cure of duodenal ulcer after eradication of Helicobacter pylori. Medical Journal of Australia 153: 145–149, 1990

    PubMed  CAS  Google Scholar 

  • Giorgi Conciato M, Daniotti S, Ferrari PA, Gaetani M, Petrin G, et al. Efficacy and safety of pirenzepine in peptic ulcer and in non ulcerous gastroduodenal diseases: a multicentre controlled clinical trial. Scandinavian Journal of Gastroenterology 17 (Suppl. 81): 1–42, 1982

    Google Scholar 

  • Glise H, Carling L, Hallerbaeck B, Hallgren T, Kagevi I, et al. Relapse rate of healed duodenal, prepyloric and gastric ulcers treated either with sucralfate or cimetidine. American Journal of Medicine 83 (Suppl. 3B): 105–109, 1987

    Article  PubMed  CAS  Google Scholar 

  • Graham DY, Agrawal NM, Roth S. Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind placebo-controlled trial. Lancet 2: 1277–1280, 1988

    Article  PubMed  CAS  Google Scholar 

  • Guslandi M. Importance of defensive factors in the prevention of peptic ulcer recurrence. Acta Gastroenterologica Belgica 46: 411–418, 1983

    CAS  Google Scholar 

  • Guslandi M. Cytoprotective drugs for peptic ulcer. Drugs of Today 24: 491–507, 1988a

    CAS  Google Scholar 

  • Guslandi M. How does smoking harm the duodenum? British Medical Journal 296: 311–312, 1988b

    Article  PubMed  CAS  Google Scholar 

  • Guslandi M. Combined therapies for upper gastrointestinal disorders: any advantage? Lancet 1: 1383–1385, 1988c

    Article  PubMed  CAS  Google Scholar 

  • Guslandi M. Comparison of sucralfate and ranitidine in the treatment of chronic nonerosive gastritis: a randomised multicenter trial. American Journal of Medicine 86 (Suppl. 6A): 45–48, 1989

    Article  PubMed  CAS  Google Scholar 

  • Guslandi M, Ballarin E. Assessment of the ‘mucus-bicarbonate’ barrier in the stomach of patients with chronic gastric disorders. Clinica Chimica Acta 144: 133–136, 1984

    Article  CAS  Google Scholar 

  • Guslandi M, Ballarin E, Tittobello A. Sucralfate in refractory duodenal ulcers. Gut 24: A498, 1983

    Article  Google Scholar 

  • Guslandi M, Daniotti S, Ballarin E, Basilico M, Tittobello A. Pirenzepine in erosive duodenitis: a controlled clinical trial versus ranitidine. Scandinavian Journal of Gastroenterology 20: 751–755, 1985

    Article  PubMed  CAS  Google Scholar 

  • Guslandi M, Masci E, Ballarin E, Imbimbo BP, Daniotti S, et al. Luminal bicarbonate outflow in chronic antral erosions is suppressed by pirenzepine. Hepato-Gastroenterology 34: 171–173, 1987

    PubMed  CAS  Google Scholar 

  • Hamilton I, O’Connor HJ, Wood NC, Bradbury I, Axon ATR. Healing and recurrence of duodenal ulcer after treatment with tripotassium dicitrato bismuthate (TDB) or cimetidine. Gut 27: 106–110, 1986

    Article  PubMed  CAS  Google Scholar 

  • Hawkey CJ, Simpson G, Somerville KW. Reduction by enprostil of aspirin-induced blood loss from human gastric mucosa. American Journal of Medicine 81 (Suppl. 2A): 50–53, 1986

    Article  PubMed  CAS  Google Scholar 

  • Hawkey CJ, Walt RP. Prostaglandins for peptic ulcer: a promise unfulfilled. Lancet 2: 1084–1087, 1986

    Article  PubMed  CAS  Google Scholar 

  • Hentschel F, Schutze K, Dufek W. Rezidive des Ulcers duodeni nach Therapie mit Sucralfat oder Cimetidin. Wiener Klinische Wochenschrift 96: 153–156, 1984

    PubMed  CAS  Google Scholar 

  • Kang JY, Piper DW. Cimetidine and colloidal bismuth in treatment of chronic duodenal ulcer: comparison of initial healing and recurrence after healing. Digestion 23: 73–79, 1982

    Article  PubMed  CAS  Google Scholar 

  • Koelz HR, Bauerfeind P. Mucosal protecting agents: first choice in uncomplicated ulcer disease? Scandinavian Journal of Gastroenterology 23 (Suppl. 153): 71–80, 1988

    Article  Google Scholar 

  • Koelz HR, Halter F. Sucralfate and ranitidine in the treatment of acute duodenal ulcer: healing and relapse. American Journal of Medicine 86 (Suppl. 6A): 98–103, 1989

    Article  PubMed  CAS  Google Scholar 

  • Konturek SJ, Kwiecien N, Obtulowicz W, Hebzda Z, Olesky J. Effects of colloidal bismuth subcitrate on aspirin-induced gastric microbleeding, DNA loss and prostaglandin formation in humans. Scandinavian Journal of Gastroenterology 23: 861–866, 1988

    Article  PubMed  CAS  Google Scholar 

  • Konturek SJ, Kwiecien N, Obtulowicz W, Kopp B, Olesky J. Double-blind controlled study on the effect of sucralfate on gastric prostaglandin formation and microbleeding in aspirin treated man. Gut 27: 1450–1456, 1986

    Article  PubMed  CAS  Google Scholar 

  • Konturek SJ, Pawlik W. Physiology and pharmacology of prostaglandins. Digestive Diseases and Sciences 31 (Suppl. 2): 6S–19S, 1986

    Article  PubMed  CAS  Google Scholar 

  • Lam SK. Implications of sucralfate-induced ulcer healing and relapse. American Journal of Medicine 86 (Suppl. 6A): 122–126, 1989

    Article  PubMed  CAS  Google Scholar 

  • Lam SK, Hui WM, Lau WY, Branicki FJ, Lai CL, et al. Sucralfate overcomes adverse effect of cigarette smoking on duodenal ulcer healing and prolongs subsequent remission. Gastroenterology 93: 1193–1201, 1987

    Google Scholar 

  • Lam SK, Lau WY, Choi TK, Lai CL, Lok ASF, et al. Prostaglandin E1 (misoprostol) overcomes the adverse effect of chronic cigarette smoking on duodenal ulcer healing. Digestive Diseases and Sciences 31 (Suppl. 2): 68S–74S, 1986

    Article  PubMed  CAS  Google Scholar 

  • Urn SK, Lee NW, Koo J, Hui WM, Fok HK, et al. Randomised crossover trial of tripotassium dicitrato bismuthate versus high dose cimetidine for duodenal ulcer resistant to standard dose of cimetidine. Gut 25: 703–706, 1984

    Article  Google Scholar 

  • Lane MR, Lee SP. Recurrence of duodenal ulcer after medical treatment. Lancet 1: 1147–1149, 1988

    Article  PubMed  CAS  Google Scholar 

  • Lanza FL. A double-blind study of prophylactic effect of misoprostol on lesions of gastric and duodenal mucosa induced by oral administration of tolmetin in healthy subjects. Digestive Diseases and Sciences 31 (Suppl. 2): 131S–136S, 1986

    Article  PubMed  CAS  Google Scholar 

  • Lanza FL, Aspinall RL, Swabb EA, Davis RE, Rack MF, et al. Double-blind placebo-controlled endoscopie comparison of the mucosal protective effects of misoprostol versus cimetidine on tolmetin-induced mucosal injury to the stomach and duodenum. Gastroenterology 95: 289–294, 1988a

    PubMed  CAS  Google Scholar 

  • Lanza FL, Fakouhi D, Rubin A, Davis RE, Rack MF, et al. A double-blind placebo-controlled comparison of the efficacy and safety of 50, 100 and 200mcg of misoprostol qid in the prevention of ibuprofen-induced gastric and duodenal mucosal lesions and symptoms. American Journal of Gastroenterology 84: 633–636, 1989

    PubMed  CAS  Google Scholar 

  • Lanza FL, Peace K, Gustitus L, Rack MF, Dickson B. A blinded endoscopic comparative study of misoprostol versus sucralfate and placebo in the prevention of aspirin-induced gastric and duodenal ulceration. American Journal of Gastroenterology 83: 143–146, 1988b

    PubMed  CAS  Google Scholar 

  • Lee FI, Samloff IM, Hardman M. Comparison of tri-potassium dicitrato bismuthate tablets with ranitidine in healing and relapse of duodenal ulcers. Lancet 1: 1299–1302, 1985

    Article  PubMed  CAS  Google Scholar 

  • Loffeld RJ, Potters HV, Stobberingh E, Flendring JA, Van Spreeuwel JP, et al. Campylobacter associated gastritis in patients with non-ulcer dyspepsia: a double blind placebo controlled trial with colloidal bismuth subcitrate. Gut 30: 1206–1212, 1989

    Article  PubMed  CAS  Google Scholar 

  • Malchow-Moller A, Ranlov PJ. Does sucralfate reduce acetylsalicylic acid-induced gastric mucosal bleeding? Scandinavian Journal of Gastroenterology 22: 550–552, 1987

    Article  PubMed  CAS  Google Scholar 

  • Manniche C, Malchow-Moller A, Andersen JR, Pedersen C, Hansen TM, et al. Randomised study of the influence of non-steroidal anti-inflammatory drugs on the treatment of peptic ulcer in patients with rheumatic disease. Gut 28: 226–229, 1987

    Article  PubMed  CAS  Google Scholar 

  • Marks IN, Wright JP, Lucke W, Girdwood AH. Relapse rates after initial healing with sucralfate or cimetidine. Scandinavian Journal of Gastroenterology 17: 429–432, 1982

    Article  PubMed  CAS  Google Scholar 

  • Marshall BJ, Warren JR, Blincow ED, Phillips M, Goodwin CS, et al. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter Pylori. Lancet 2: 1437–1441, 1988

    Article  PubMed  CAS  Google Scholar 

  • Martin DF, Hollanders D, May SJ, et al. Differences in relapse rates of duodenal ulcer after healing with cimetidine or tripotassium dicitrato-bismuthate. Lancet 1: 7–10, 1981

    Article  PubMed  CAS  Google Scholar 

  • McLean AJ, Byrne AJ, Harrison PM, McCarthy P, Ionnides-Demos L, et al. The choice of ulcer healing agent influences duodenal ulcer relapse rate and long-term clinical outcome. Australian and New Zealand Journal of Medicine 15: 367–374, 1985

    Article  PubMed  CAS  Google Scholar 

  • McLean AJ, Harcourt DM, McNeil JJ. Relapse rate as a major determinant of drug selection in peptic ulcer therapy. Drugs 35: 329–333, 1988

    Article  PubMed  CAS  Google Scholar 

  • Miller JP, Faragher EB. Relapse of duodenal ulcer: does it matter which drug is used in the initial treatment? British Medical Journal 293: 1117–1118, 1986

    Article  PubMed  CAS  Google Scholar 

  • Newman RD, Gitlin N, Lacayo EJ, Safdi AV, Ramsey EJ, et al. Misoprostol in the treatment of duodenal ulcer refractory to H2-blocker therapy: a placebo-controlled, multicenter, double-blind, randomized trial. American Journal of Medicine 83 (Suppl. 1A): 27–31, 1987

    Article  PubMed  CAS  Google Scholar 

  • Penston JG, Wormsley KB. Histamine H2-receptor antagonists versus prostaglandins in the treatment of peptic ulcer disease. Drugs 37: 391–401, 1989

    Article  PubMed  CAS  Google Scholar 

  • Rachmilewitz D. The role of H2 receptor antagonists in the prevention of NSAID-induced gastrointestinal damage. Alimentary Pharmacology and Therapeutics 2 (Suppl. 1): 65–73, 1988

    PubMed  Google Scholar 

  • Rainsford KD. Mechanisms of gastrointestinal toxicity of non-steroidal anti-inflammatory drugs. Scandinavian Journal of Gastroenterology 24 (Suppl. 163): 9–16, 1989

    Article  Google Scholar 

  • Rauws EAJ, Langenberg W, Houthoff HJ, Zanen HC, Tytgat GNJ. Campylobacter pyloridis-associated chronic active antral gastritis: a prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology 94: 33–40, 1988

    PubMed  CAS  Google Scholar 

  • Robert A. Cytoprotection by prostaglandins. Gastroenterology 77: 761–767, 1979

    PubMed  CAS  Google Scholar 

  • Rokkas T, Pursey C, Uzoechina E, Dorrington L, Simmons NA, et al. Non-ulcer dyspepsia and short term De-Nol therapy: a placebo controlled trial with particular reference to the role of Campylobacter Pylori. Gut 29: 1386–1391, 1988

    Article  PubMed  CAS  Google Scholar 

  • Ryan JR, Vargas R, Clay GA, McMahon FG. Role of misoprostol in reducing aspirin-induced gastrointestinal blood loss in arthritic patients. American Journal of Medicine 83 (Suppl. 1A): 37–40, 1987

    Google Scholar 

  • Salmon PR. Combination treatment: colloidal busmuth subcitrate with H2-antagonists. Digestion 37 (Suppl. 2): 42–46, 1987

    Article  PubMed  Google Scholar 

  • Scarpignato C. Pirenzepine and mucosal protection: an overview. In Cheli R & Molinari F (Eds) Pirenzepine: knowledge and new trends, pp. 75–88, Cortina International, Verona, 1986

    Google Scholar 

  • Shreeve DR, Klass HJ, Jones PE. Comparison of cimetidine and tripotassium dicitrato-bismuthate in healing and relapse of duodenal ulcers. Digestion 28: 96–101, 1983

    Article  PubMed  CAS  Google Scholar 

  • Silverstein FE, Kimmey MB, Saunders DR, Levine DS. Gastric protection by misoprostol against 1300mg of aspirin: an endoscopic study. Digestive Diseases and Sciences 31 (Suppl. 2): 137S–141S, 1986

    Article  PubMed  CAS  Google Scholar 

  • Stern AI, Ward F, Sievert W. Lack of gastric mucosal protection by sucralfate during long-term aspirin ingestion in humans. American Journal of Medicine 86 (Suppl. 6A): 66–69, 1989

    Article  PubMed  CAS  Google Scholar 

  • Stiel D, Ellard KT, Hills LJ, Brooks PM. Protective effect of enprostil against aspirin-induced gastroduodenal mucosal injury in man: comparison with cimetidine and sucralfate. American Journal of Medicine 81 (Suppl. 2A): 54–58, 1986

    Article  PubMed  CAS  Google Scholar 

  • Tarnawski A, Hollander D, Stachura J, Krause WJ, Gergely H. Prostaglandin protection of the gastric mucosa against alcohol injury: a dynamic time-related process. Role of the mucosal proliferative zone. Gastroenterology 88: 334–352, 1985

    PubMed  CAS  Google Scholar 

  • Tesler MA, Lim ES. Protection of gastric mucosa by sucralfate from aspirin-induced erosions. Journal of Clinical Gastroenterology 3 (Suppl. 2): 175–180, 1981

    Article  PubMed  CAS  Google Scholar 

  • Tolman KG, Detweiler MK, Harrison CA, Rollins DE, Simon DA, et al. Effect of rioprostil on aspirin-induced gastrointestinal mucosal changes in normal volunteers. Journal of Clinical Pharmacology 28: 76–80, 1988

    PubMed  CAS  Google Scholar 

  • Tovey FI, Husband EM, Yiu YC, Baker L, McPhail G, et al. Comparison of relapse rates and of mucosal abnormalities after healing of duodenal ulceration and after one year’s maintenance with cimetidine or sucralfate: a light and electron microscopy study. Gut 30: 586–593, 1989

    Article  PubMed  CAS  Google Scholar 

  • Van Deventer GM, Schneidman D, Walsh JH. Sucralfate and cimetidine as single agents and in combination for treatment of active duodenal ulcer a double-blind, placebo-controlled trial. American Journal of Medicine 79 (Suppl. 2C): 39–44, 1985

    Article  PubMed  Google Scholar 

  • Vantrappen G, Schuurmans P, Rutgeerts P, Janssens J. A comparative study of colloidal bismuth subcitrate and cimetidine on the healing and recurrence of duodenal ulcer. Scandinavian Journal of Gastroenterology 17 (Suppl. 80): 21–30, 1982

    Google Scholar 

  • Wagstaff AJ, Benfield P, Monk JP. Colloidal bismuth subcitrate: a review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease. Drugs 36: 132–157, 1988

    Article  PubMed  CAS  Google Scholar 

  • Weberg R, Berstad A. Low-dose antacids and pirenzepine in the treatment of patients with non-ulcer dyspepsia and erosive prepyloric changes: a randomized, double-blind, placebo-controlled trial. Scandinavian Journal of Gastroenterology 23: 237–243, 1988

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Servizio di Gastroenterologia, Ospedale S. Raffaele, Via Olgettina 60, 20132, Milano, Italy

    Mario Guslandi

Authors
  1. Mario Guslandi
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Guslandi, M. Gastric Cytoprotection. Drugs 41, 507–513 (1991). https://doi.org/10.2165/00003495-199141040-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199141040-00001

Keywords

Search

Navigation